PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

70 hedge funds and large institutions have $116M invested in Invesco Biotechnology & Genome ETF in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-4
Holders Change %
-5.41%
% of All Funds
2.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
18
Reduced
20
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BWP
Baldwin Wealth Partners
Massachusetts
$1.53M
2
NDSI
Newman Dignan & Sheerar Inc
Rhode Island
$1.31M
3
MCM
Murphy Capital Management
New Jersey
$238K
4
GT
Glenmede Trust
Pennsylvania
$168K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$3.14M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
$26.8M
2
VKH
Virtu KCG Holdings
New York
$0
3
Goldman Sachs
Goldman Sachs
New York
$3.03M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$474K
5
CWM
Concert Wealth Management
California
$896K
Name Holding Trade Value Shares
Change 		Shares
Change %
SG Americas Securities
76
SG Americas Securities
New York
– -$119K -2,723 Closed
BRWA
77
B. Riley Wealth Advisors
Florida
– -$54.3K -1,241 Closed
Bank of Montreal
78
Bank of Montreal
Ontario, Canada
– -$44K -1,000 Closed
FCCM
79
First City Capital Management
Georgia
– -$27.3K -625 Closed
BRWM
80
B. Riley Wealth Management
Tennessee
– -$26K -610 Closed
WTB
81
Washington Trust Bank
Washington
– -$14K -321 Closed
GSC
82
Ground Swell Capital
South Carolina
– -$5K -105 Closed
1 2 3
4